Page last updated: 2024-10-26

dibucaine and Leukemia L5178

dibucaine has been researched along with Leukemia L5178 in 1 studies

Dibucaine: A local anesthetic of the amide type now generally used for surface anesthesia. It is one of the most potent and toxic of the long-acting local anesthetics and its parenteral use is restricted to spinal anesthesia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1006)
cinchocaine : A monocarboxylic acid amide that is the 2-(diethylamino)ethyl amide of 2-butoxyquinoline-4-carboxylic acid. One of the most potent and toxic of the long-acting local anesthetics, its parenteral use was restricted to spinal anesthesia. It is now generally only used (usually as the hydrochloride) in creams and ointments and in suppositories for temporary relief of pain and itching associated with skin and anorectal conditions.

Leukemia L5178: An experimental lymphocytic leukemia of mice.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vaughan, VL1
Stadler, JK1

Other Studies

1 other study available for dibucaine and Leukemia L5178

ArticleYear
Isolation and genetic characterization of dibucaine-resistant variants of a mouse lymphocytic cell line.
    Experimental cell research, 1980, Volume: 130, Issue:1

    Topics: Animals; Benzocaine; Cell Division; Cell Line; Dibucaine; Dose-Response Relationship, Drug; Drug Res

1980